Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 23594419)

1.

Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature.

Arends M, van Dussen L, Biegstraaten M, Hollak CE.

Br J Haematol. 2013 Jun;161(6):832-42. doi: 10.1111/bjh.12335. Epub 2013 Apr 18. Review.

PMID:
23594419
2.

Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature.

de Fost M, Out TA, de Wilde FA, Tjin EP, Pals ST, van Oers MH, Boot RG, Aerts JF, Maas M, Vom Dahl S, Hollak CE.

Ann Hematol. 2008 Jun;87(6):439-49. doi: 10.1007/s00277-008-0441-8. Epub 2008 Feb 15.

3.

Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.

Mistry PK, Taddei T, vom Dahl S, Rosenbloom BE.

Crit Rev Oncog. 2013;18(3):235-46. Review.

4.

Gaucher disease and cancer incidence: a study from the Gaucher Registry.

Rosenbloom BE, Weinreb NJ, Zimran A, Kacena KA, Charrow J, Ward E.

Blood. 2005 Jun 15;105(12):4569-72. Epub 2005 Feb 17.

5.

Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.

Hughes D, Cappellini MD, Berger M, Van Droogenbroeck J, de Fost M, Janic D, Marinakis T, Rosenbaum H, Villarubia J, Zhukovskaya E, Hollak C.

Br J Haematol. 2007 Sep;138(6):676-86. Epub 2007 Jul 26.

6.

Effect of treatment on biclonal gammopathy associated with Gaucher disease.

Decaux O, Ruelland A, Grosbois B.

J Inherit Metab Dis. 2007 Oct;30(5):824. Epub 2007 Sep 21.

PMID:
17879146
7.

Gaucher disease and monoclonal gammopathy: a report of 17 cases and impact of therapy.

Grosbois B, Rose C, Noël E, Serratrice Cde R, Dobbelaere D, Gressin V, Chérin P, Hartmann A, Javier RM, Clerson P, Hachulla E, Jaussaud R; Investigators of the French Observatoire on Gaucher Disease.

Blood Cells Mol Dis. 2009 Jul-Aug;43(1):138-9. doi: 10.1016/j.bcmd.2009.04.002. Epub 2009 May 8. No abstract available.

PMID:
19427246
8.

Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.

Biegstraaten M, Mengel E, Maródi L, Petakov M, Niederau C, Giraldo P, Hughes D, Mrsic M, Mehta A, Hollak CE, van Schaik IN.

Brain. 2010 Oct;133(10):2909-19. doi: 10.1093/brain/awq198. Epub 2010 Aug 7.

9.

Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic.

Zimran A, Liphshitz I, Barchana M, Abrahamov A, Elstein D.

Blood Cells Mol Dis. 2005 May-Jun;34(3):197-200.

PMID:
15885601
10.
11.

Increased incidence of cancer in adult Gaucher disease in Western Europe.

de Fost M, Vom Dahl S, Weverling GJ, Brill N, Brett S, Häussinger D, Hollak CE.

Blood Cells Mol Dis. 2006 Jan-Feb;36(1):53-8. Epub 2005 Oct 24.

PMID:
16246599
12.

Triangular approach for the diagnosis of monoclonal gammopathy in malignancies.

Kulkarni SA, Shrikhande AV.

Indian J Cancer. 2002 Jun;39(2):45-54.

PMID:
12789724
13.

Effect of enzyme replacement therapy on gammopathies in Gaucher disease.

Brautbar A, Elstein D, Pines G, Abrahamov A, Zimran A.

Blood Cells Mol Dis. 2004 Jan-Feb;32(1):214-7.

PMID:
14757437
14.

Gaucher disease and myeloma.

Ayto R, Hughes DA.

Crit Rev Oncog. 2013;18(3):247-68. Review.

PMID:
23510067
15.

Splenic lymphoma arising in a patient with Gaucher disease. A case report and review of the literature.

Bertram HC, Eldibany M, Padgett J, Dragon LH.

Arch Pathol Lab Med. 2003 May;127(5):e242-5. Review.

PMID:
12708922
16.

Risk of malignant disease among 1525 adult male US Veterans with Gaucher disease.

Landgren O, Turesson I, Gridley G, Caporaso NE.

Arch Intern Med. 2007 Jun 11;167(11):1189-94.

PMID:
17563029
17.

Silicone gel implants and monoclonal gammopathies: three cases of multiple myeloma and the prevalence of multiple myeloma and monoclonal gammopathy of undetermined significance.

Silverman S, Vescio R, Silver D, Renner S, Weiner S, Berenson J.

Curr Top Microbiol Immunol. 1996;210:367-74. No abstract available.

PMID:
8565579
18.

'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature.

Biegstraaten M, van Schaik IN, Aerts JM, Hollak CE.

J Inherit Metab Dis. 2008 Jun;31(3):337-49. doi: 10.1007/s10545-008-0832-y. Epub 2008 Apr 4. Review.

PMID:
18404411
19.

Increased risk of cancer in patients with Gaucher disease.

Shiran A, Brenner B, Laor A, Tatarsky I.

Cancer. 1993 Jul 1;72(1):219-24.

PMID:
8508410
20.

Lymphoplasmacytic lymphoma with monoclonal gammopathy-related pseudo-Gaucher cell infiltration in bone marrow and spleen--diagnostic and therapeutic dilemmas.

Robak T, Urbańska-Ryś H, Jerzmanowski P, Bartkowiak J, Liberski P, Kordek R.

Leuk Lymphoma. 2002 Dec;43(12):2343-50.

PMID:
12613522
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk